Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
251
-
Total 13F shares, excl. options
-
56.6M
-
Shares change
-
+4.95M
-
Total reported value, excl. options
-
$795M
-
Value change
-
+$69.1M
-
Put/Call ratio
-
0.15
-
Number of buys
-
110
-
Number of sells
-
-113
-
Price
-
$14.04
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q2 2022
299 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q2 2022.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 251 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56.6M shares
.
Largest 10 shareholders include Mondrian Investment Partners LTD (4.75M shares), MORGAN STANLEY (4.24M shares), MACQUARIE GROUP LTD (4.07M shares), GOLDMAN SACHS GROUP INC (3.63M shares), RENAISSANCE TECHNOLOGIES LLC (2.83M shares), NORTHERN TRUST CORP (2.26M shares), BlackRock Inc. (2.18M shares), BRANDES INVESTMENT PARTNERS, LP (2.02M shares), VAN ECK ASSOCIATES CORP (1.99M shares), and FMR LLC (1.85M shares).
This table shows the top 251 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.